1. Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation. 1986; 74:469–476.
2. Kilian JG, Keech A, Adams MR, Celermajer DS. Coronary collateralization: determinants of adequate distal vessel filling after arterial occlusion. Coron Artery Dis. 2002; 13:155–159.
3. van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, Schaper W. Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc Res. 2001; 49:543–553.
4. Papaioannou TG, Stefanadis C. Vascular wall shear stress: basic principles and methods. Hellenic J Cardiol. 2005; 46:9–15.
5. Sloop G, Holsworth RE Jr, Weidman JJ, St Cyr JA. The role of chronic hyperviscosity in vascular disease. Ther Adv Cardiovasc Dis. 2015; 9:19–25.
6. Cho YI, Cho DJ, Rosenson RS. Endothelial shear stress and blood viscosity in peripheral arterial disease. Curr Atheroscler Rep. 2014; 16:404.
7. de Simone G, Devereux RB, Chien S, Alderman MH, Atlas SA, Laragh JH. Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation. 1990; 81:107–117.
8. Shah PB. Management of coronary chronic total occlusion. Circulation. 2011; 123:1780–1784.
9. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol. 1985; 5:587–592.
10. Sloop GD, Garber DW. The effects of low-density lipoprotein and high-density lipoprotein on blood viscosity correlate with their association with risk of atherosclerosis in humans. Clin Sci (Lond). 1997; 92:473–479.
11. Blann A, Bignell A, McCollum C. von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosity. Atherosclerosis. 1998; 139:317–322.
12. Muggeo M, Calabrò A, Businaro V, Moghetti P, Padovan D, Crepaldi G. Correlation of metabolic and hemorrheological parameters in diabetes and hyperlipidemia. Ric Clin Lab. 1983; 13:Suppl 3. 165–179.
13. Wasilewski J, Turczyński B, Słowińska L, Kowalik V, Osadnik T, Poloński L. Haemorheological factors and myocardial reperfusion in patients with ST-elevation myocardial infarction undergoing primary coronary intervention. Kardiol Pol. 2007; 65:778–785. discussion 786-7.
14. Empen K, Geiss HC, Lehrke M, Otto C, Schwandt P, Parhofer KG. Effect of atorvastatin on lipid parameters, LDL subtype distribution, hemorrheological parameters and adhesion molecule concentrations in patients with hypertriglyceridemia. Nutr Metab Cardiovasc Dis. 2003; 13:87–92.
15. Mellwig KP, Baller D, Schmidt HK, et al. Myocardial perfusion under H.E.L.P.-apheresis. Objectification by PET. Z Kardiol. 2003; 92:Suppl 3. III30–III37.
16. Arntz HR, Perchalla G, Roll D, Heitz J, Schäfer JH, Schröder R. Blood rheology in acute myocardial infarction: effects of high-dose i.v. streptokinase compared to placebo. Eur Heart J. 1992; 13:275–280.
17. Mohandas N, Chasis JA, Shohet SB. The influence of membrane skeleton on red cell deformability, membrane material properties, and shape. Semin Hematol. 1983; 20:225–242.
18. Hansen JF. Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion. Am Heart J. 1989; 117:290–295.
19. Nacar AB, Erayman A, Kurt M, et al. The relationship between coronary collateral circulation and neutrophil/lymphocyte ratio in patients with coronary chronic total occlusion. Med Princ Pract. 2015; 24:65–69.
20. Börekçi A, Gür M, Şeker T, et al. Coronary collateral circulation in patients with chronic coronary total occlusion; its relationship with cardiac risk markers and SYNTAX score. Perfusion. 2015; 30:457–464.
21. Yaylali YT, Susam I, Demir E, et al. Increased red blood cell deformability and decreased aggregation as potential adaptive mechanisms in the slow coronary flow phenomenon. Coron Artery Dis. 2013; 24:11–15.
22. Soulis JV, Farmakis TM, Giannoglou GD, et al. Molecular viscosity in the normal left coronary arterial tree. Is it related to atherosclerosis? Angiology. 2006; 57:33–40.
23. Biro GP, Beresford-Kroeger D, Hendry P. Early deleterious hemorheologic changes following acute experimental coronary occlusion and salutary antihyperviscosity effect of hemodilution with stroma-free hemoglobin. Am Heart J. 1982; 103:870–878.
24. Biro GP, Beresford-Kroeger D. The effect of hemodilution with stroma-free hemoglobin and dextran on collateral perfusion of ischemic myocardium in the dog. Am Heart J. 1980; 99:64–75.
25. Doi H, Kaburaki M, Inoue H, Suzumura K, Narita H. Protective effect of TA-993, a novel therapeutic agent for peripheral circulatory insufficiency, on skeletal muscle fatigue in a rat model of hindlimb ischemia. Jpn J Pharmacol. 2000; 83:73–81.
26. van Gaal WJ, Ponnuthurai FA, Selvanayagam J, et al. The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention. Int J Cardiol. 2009; 135:60–65.
27. Kyriakides ZS, Kremastinos DT, Michelakakis NA, Matsakas EP, Demovelis T, Toutouzas PK. Coronary collateral circulation in coronary artery disease and systemic hypertension. Am J Cardiol. 1991; 67:687–690.
28. Junker R, Heinrich J, Ulbrich H, et al. Relationship between plasma viscosity and the severity of coronary heart disease. Arterioscler Thromb Vasc Biol. 1998; 18:870–875.